Current advances and challenges in the development of Acinetobacter vaccines
W Chen - Human vaccines & immunotherapeutics, 2015 - Taylor & Francis
Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
Current advances and challenges in the development of Acinetobacter vaccines.
W Chen - Human Vaccines & Immunotherapeutics, 2015 - europepmc.org
Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
[HTML][HTML] Current advances and challenges in the development of Acinetobacter vaccines
W Chen - Human Vaccines & Immunotherapeutics, 2015 - ncbi.nlm.nih.gov
Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
Current advances and challenges in the development of Acinetobacter vaccines
W Chen - Human vaccines & immunotherapeutics, 2015 - pubmed.ncbi.nlm.nih.gov
Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …